Clinical Trial

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Study acronym: CiGal-EI-TEP
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-01; most recent amendment 2026-01-30.
Status change: Not Yet Recruiting → Recruiting 2024-11-22
Trial Details
NCT Number NCT05446376
Lead Sponsor University Hospital, Bordeaux
Conditions Infective Endocarditis
Enrollment 40 participants
Start Date 2024-11-22
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-03